Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis

World Journal of Gastroenterology

Volumn 21, Issue 38, 2015, Pages 10732-10738

  Geng, Ming ^a   Xin, Xuan ^a   Bi, Li Quan ^a   Zhou, Lu Ting ^a   Liu, Xiao Hong ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Hepatitis B virus; Hepatitis B virus X protein; Hepatocarcinogenesis; Hepatocellular carcinoma

Indexed keywords

BETA CATENIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; HEPATITIS B VIRUS X PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LONG UNTRANSLATED RNA; MICRORNA 101; MICRORNA 145; MICRORNA 21; MICRORNA 222; MITOCHONDRIAL DNA; PIWI INTERACTING RNA; PROTEIN P53; SMALL NUCLEAR RNA; SMALL NUCLEOLAR RNA; UNTRANSLATED RNA; WNT PROTEIN; MICRORNA; TRANSACTIVATOR PROTEIN;

ARTICLE; DNA METHYLATION; DNA REPAIR; GENE EXPRESSION; GENOMIC INSTABILITY; HEPATITIS B; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; METASTASIS; MOLECULAR PATHOLOGY; NONHUMAN; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS GENOME; WNT SIGNALING PATHWAY; ANIMAL; CELL MOTION; CELL PROLIFERATION; GENETICS; LIVER TUMOR; METABOLISM; VIROLOGY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; DNA REPAIR; HUMANS; LIVER NEOPLASMS; MICRORNAS; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84944104214     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i38.10732     Document Type: Article

References (64)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29 [PMID: 22237781 DOI: 10.3322/caac.20138]
2. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73 [PMID: 16391218]
3. Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris) 2010; 58: 273-277 [PMID: 20378277 DOI: 10.1016/j.patbio.2010.01.005]
4. Zhang XD, Wang Y, Ye LH. Hepatitis B virus X protein accelerates the development of hepatoma. Cancer Biol Med 2014; 11: 182-190 [PMID: 25364579 DOI: 10.7497/j.issn.2095-3941.2014.03.004]
5. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68 [PMID: 10704474]
6. Venard V, Corsaro D, Kajzer C, Bronowicki JP, Le Faou A. Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma. J Med Virol 2000; 62: 177-184 [PMID: 11002246]
7. Kramvis A, Kew MC. The core promoter of hepatitis B virus. J Viral Hepat 1999; 6: 415-427 [PMID: 10607259]
8. Cheng B, Zheng Y, Guo X, Wang Y, Liu C. Hepatitis B viral X protein alters the biological features and expressions of DNA repair enzymes in LO2 cells. Liver Int 2010; 30: 319-326 [PMID: 19968784 DOI: 10.1111/j.1478-3231.2009.02167.x]
9. Jung SY, Kim YJ. C-terminal region of HBx is crucial for mitochondrial DNA damage. Cancer Lett 2013; 331: 76-83 [PMID: 23246371 DOI: 10.1016/j.canlet.2012.12.004]
10. Capovilla A, Carmona S, Arbuthnot P. Hepatitis B virus X-protein binds damaged DNA and sensitizes liver cells to ultraviolet irradiation. Biochem Biophys Res Commun 1997; 232: 255-260 [PMID: 9125143]
11. Tian Y, Yang W, Song J, Wu Y, Ni B. Hepatitis B virus X proteininduced aberrant epigenetic modifcations contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol 2013; 33: 2810-2816 [PMID: 23716588 DOI: 10.1128/MCB.00205-13]
12. Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X, Wu Z. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cell Signal 2013; 25: 439-446 [PMID: 23124077 DOI: 10.1016/j.cellsig.2012.10.013]
13. Zhu YZ, Zhu R, Shi LG, Mao Y, Zheng GJ, Chen Q, Zhu HG. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyl-transferases in hepatocarcinogenesis. Exp Mol Pathol 2010; 89: 268-275 [PMID: 20620135 DOI: 10.1016/j.yexmp.2010.06.013]
14. Nana-Sinkam SP, Croce CM. Non-coding RNAs in cancer initiation and progression and as novel biomarkers. Mol Oncol 2011; 5: 483-491 [PMID: 22079056 DOI: 10.1016/j.molonc.2011.10.003]
15. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297 [PMID: 14744438]
16. Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB, Chen Y. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Eur J Cancer 2014; 50: 2560-2569 [PMID: 25087183 DOI: 10.1016/j.ejca.2014.07.008]
17. Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao Y, Li Y, Zeng T, Hu J, Zhang L, Zhang L, Fan H. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene 2013; 32: 3296-3305 [PMID: 23604124 DOI: 10.1038/onc.2013.150]
18. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese G V, Ciafrè SA, Farace MG. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007; 282: 23716-23724 [PMID: 17569667]
19. Bandopadhyay M, Banerjee A, Sarkar N, Panigrahi R, Datta S, Pal A, Singh SP, Biswas A, Chakrabarti S, Chakravarty R. Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytes. BMC Cancer 2014; 14: 721 [PMID: 25260533 DOI: 10.1186/1471-2407-14-721]
20. Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, Zhu Z, Jiao H, Lin J, Jiang K, Ding L, Zhang H, Cheng L, Fu H, Song Y, Jiang Y, Liu J, Wang R, Du N, Ye Q. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest 2013; 123: 630-645 [PMID: 23321675 DOI: 10.1172/JCI64265]
21. Xie QH, He XX, Chang Y, Jiang X, Lin JS. [HBx gene down-regulates miR-192 expression and inhibits apoptosis of human hepatoma cell line HepG2]. Zhonghua Gan Zang Bing Zazhi 2011; 19: 857-860 [PMID: 22433310 DOI: 10.3760/cma.j.issn.1007-341 8.2011.11.015]
22. He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW, Li J. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. Cancer Lett 2014; 344: 20-27 [PMID: 24183851 DOI: 10.1016/j.canlet.2013.10.021]
23. Du Y, Kong G, You X, Zhang S, Zhang T, Gao Y, Ye L, Zhang X. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem 2012; 287: 26302-26311 [PMID: 22685290 DOI: 10.1074/jbc.M112.342113]
24. Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang Y, Tang GN, Zhou WP, Sun SH. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate flament protein vimentin. Hepatology 2013; 57: 1882-1892 [PMID: 23239537 DOI: 10.1002/hep.26195]
25. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001; 36: 651-660 [PMID: 11686474]
26. Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C, Kremsdorf D. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res 2001; 61: 7803-7810 [PMID: 11691796]
27. Wang Q, Zhang T, Ye L, Wang W, Zhang X. Analysis of hepatitis B virus X gene (HBx) mutants in tissues of patients suffered from hepatocellular carcinoma in China. Cancer Epidemiol 2012; 36: 369-374 [PMID: 22178505 DOI: 10.1016/j.canep]
28. Xie Y, Liu S, Zhao Y, Guo Z, Xu J. X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma. Tumour Biol 2014; 35: 10325-10331 [PMID: 25034530 DOI: 10.1007/s13277-014-2331-0]
29. Liu XH, Lin J, Zhang SH, Zhang SM, Feitelson MA, Gao HJ, Zhu MH. COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma. World J Gastroenterol 2008; 14: 1346-1352 [PMID: 18322946 DOI: 10.3748/wjg.14.1346]
30. Hsia CC, Yuwen H, Tabor E. Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma. Lancet 1996; 348: 625-626 [PMID: 8774611]
31. Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol 1998; 143: 2313-2326 [PMID: 9930189]
32. Kim DC, Chung WJ, Lee JH, Jang BK, Hwang JS, Kang KJ, Kwon SY. Clinicopathological characteristics of PIK3CA and HBx mutations in Korean patients with hepatocellular carcinomas. APMIS 2014; 122: 1001-1006 [PMID: 24673525 DOI: 10.1111/apm.12245]
33. Baptista M, Kramvis A, Kew MC. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 1999; 29: 946-953 [PMID: 10051502]
34. Iavarone M, Trabut JB, Delpuech O, Carnot F, Colombo M, Kremsdorf D, Bréchot C, Thiers V. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. J Hepatol 2003; 39: 253-261 [PMID: 12873823]
35. Song LH, Duy DN, Binh VQ, Luty AJ, Kremsner PG, Bock CT. Low frequency of mutations in the X gene, core promoter and precore region of hepatitis B virus infected Vietnamese. J Viral Hepat 2005; 12: 160-167 [PMID: 15720531]
36. Chen GG, Li MY, Ho RL, Chak EC, Lau WY, Lai PB. Identifcation of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma. J Clin Virol 2005; 34: 7-12 [PMID: 16087118]
37. Wang D, Cai H, Yu WB, Yu L. Identifcation of hepatitis B virus X gene variants between hepatocellular carcinoma tissues and pericarcinoma liver tissues in Eastern China. Int J Clin Exp Pathol 2014; 7: 5988-5996 [PMID: 25337243]
38. Liu X, Wang L, Zhang S, Lin J, Zhang S, Feitelson MA, Gao H, Zhu M. Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses. Carcinogenesis 2008; 29: 1207-1214 [PMID: 18477650 DOI: 10.1093/carcin/bgn111]
39. Liu X, Zhang S, Lin J, Zhang S, Feitelson MA, Gao H, Zhu M. Hepatitis B virus X protein mutants exhibit distinct biological activities in hepatoma Huh7 cells. Biochem Biophys Res Commun 2008; 373: 643-647 [PMID: 18602370 DOI: 10.1016/j.bbrc.2008.06.087]
40. Liu F, You X, Chi X, Wang T, Ye L, Niu J, Zhang X. Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT. Biochem Biophys Res Commun 2014; 444: 128-134 [PMID: 24434140 DOI: 10.1016/j.bbrc.2014.01.004]
41. Wang Q, Zhang W, Liu Q, Zhang X, Lv N, Ye L, Zhang X. A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase. Neoplasia 2010; 12: 103-115 [PMID: 20126469]
42. Fu XY, Tan DM, Hou ZH, Hu ZL, Liu GZ, Ouyang Y, Liu F. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes]. Zhonghua Gan Zang Bing Zazhi 2012; 20: 598-604 [PMID: 23207154 DOI: 10.3760/cma.j.issn.1007-3418.2012.08.012]
43. Liu LP, Hu BG, Ye C, Ho RL, Chen GG, Lai PB. HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma. Br J Cancer 2014; 110: 1066-1073 [PMID: 24346287 DOI: 10.1038/bjc.2013.787]
44. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H, Harris CC. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 1997; 94: 14707-14712 [PMID: 9405677]
45. Xian L, Zhao J, Wang J, Fang Z, Peng B, Wang W, Ji X, Yu L. p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2. Mol Biol Rep 2010; 37: 2935-2940 [PMID: 19842060 DOI: 10.1007/s11033-009-9855-1]
46. Kew MC. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol 2011; 26 Suppl 1: 144-152 [PMID: 21199526 DOI: 10.1111/j.1440-1746.2010.06546.x]
47. Jiang W, Wang XW, Unger T, Forgues M, Kim JW, Hussain SP, Bowman E, Spillare EA, Lipsky MM, Meck JM, Cavalli LR, Haddad BR, Harris CC. Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line. Int J Cancer 2010; 127: 1011-1020 [PMID: 20017137 DOI: 10.1002/ijc.25118]
48. Yan J, Yao Z, Hu K, Zhong Y, Li M, Xiong Z, Deng M. Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53. Dig Dis Sci 2015; 60: 1315-1324 [PMID: 25567052]
49. Luo J, Zhou H, Wang F, Xia X, Sun Q, Wang R, Cheng B. The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells. Int J Oncol 2013; 42: 1636-1643 [PMID: 23450368 DOI: 10.3892/ijo.2013.1842]
50. Lim KH, Choi HS, Park YK, Park ES, Shin GC, Kim DH, Ahn SH, Kim KH. HBx-induced NF-κB signaling in liver cells is potentially mediated by the ternary complex of HBx with p22-FLIP and NEMO. PLoS One 2013; 8: e57331 [PMID: 23483900 DOI: 10.1371/journal.pone.0057331]
51. Lee JH, Han KH, Lee JM, Park JH, Kim HS. Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection. Clin Vaccine Immunol 2011; 18: 914-921 [PMID: 21490166 DOI: 10.1128/CVI.00474-10]
52. Zhang F, Wang Q, Ye L, Feng Y, Zhang X. Hepatitis B virus X protein upregulates expression of calpain small subunit 1 via nuclear factor-kappaB/p65 in hepatoma cells. J Med Virol 2010; 82: 920-928 [PMID: 20419804 DOI: 10.1002/jmv.21753]
53. Liu LP, Liang HF, Chen XP, Zhang WG, Yang SL, Xu T, Ren L. The role of NF-kappaB in Hepatitis b virus X protein-mediated upregulation of VEGF and MMPs. Cancer Invest 2010; 28: 443-451 [PMID: 20073580 DOI: 10.3109/07357900903405959]
54. Han JM, Kang JA, Han MH, Chung KH, Lee CR, Song WK, Jun Y, Park SG. Peroxisome-localized hepatitis Bx protein increases the invasion property of hepatocellular carcinoma cells. Arch Virol 2014; 159: 2549-2557 [PMID: 24810099 DOI: 10.1007/s00705-014-2105-4]
55. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryo-genesis-a look outside the nucleus. Science 2000; 287: 1606-1609 [PMID: 10733430]
56. Kühl M, Sheldahl LC, Park M, Miller JR, Moon RT. The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 2000; 16: 279-283 [PMID: 10858654]
57. Kühl M, Sheldahl LC, Malbon CC, Moon RT. Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J Biol Chem 2000; 275: 12701-12711 [PMID: 10777564]
58. Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncol Rep 2005; 14: 1583-1588 [PMID: 16273260]
59. Grigoryan T, Wend P, Klaus A, Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss-and gain-of-function mutations of beta-catenin in mice. Genes Dev 2008; 22: 2308-2341 [PMID: 18765787 DOI: 10.1101/gad.1686208]
60. Hsieh A, Kim HS, Lim SO, Yu D Y, Jung G. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling. Cancer Lett 2011; 300: 162-172 [PMID: 20971552 DOI: 10.1016/j.canlet.2010.09.018]
61. Liu XH, Pan MH, Lu ZF, Wu B, Rao Q, Zhou ZY, Zhou XJ. Expression of Wnt-5a and its clinicopathological signifcance in hepatocellular carcinoma. Dig Liver Dis 2008; 40: 560-567 [PMID: 18294932 DOI: 10.1016/j.dld.2007.12.011]
62. Geng M, Cao YC, Chen YJ, Jiang H, Bi LQ, Liu XH. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. World J Gastroenterol 2012; 18: 1328-1338 [PMID: 22493546 DOI: 10.3748/wjg.v18.i12.1328]
63. Lin X, Wang Q, Cao Z, Geng M, Cao Y, Liu X. Differential Expression of Wnt Pathway Genes in Sporadic Hepatocellular Carcinomas Infected With Hepatitis B Virus Identified With OligoGE Arrays. Hepat Mon 2013; 13: e6192 [PMID: 23483081 DOI: 10.5812/hepatmon.6192]
64. Bi L, Liu X, Wang C, Cao Y, Mao R, Li P, Geng M. Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma. Int J Clin Exp Pathol 2014; 7: 987-995 [PMID: 24696716]